VRTX: Upcoming renal and pain launches, pivotal data, and global expansion drive growth outlook

Multiple near-term catalysts are expected, including pivotal renal data, a major IgAN launch, and key readouts in pain and rare diseases. Commercial strategies focus on clinical differentiation, patient access, and global expansion, with a vision for diversified revenue across five therapeutic pill…